Expert Interview
Discussing prime editing compared to CRISPR/Cas9 gene editing and its potential in future therapeutics
Ticker(s): PRME, VRTX, CRSPInstitution: University of Massachusetts Medical School
- Associate Professor at the RNA Therapeutics Institute at the University of Massachusetts Medical School
- Research focuses on cancer genetics using mouse models and study of genetic diseases using CRISPR genome editing
- His lab has several papers on improving prime editors at the molecular level as well as a series in vivo application of novel CRISPR-based techniques to correct or study genetic diseases in mouse models.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
